Taking CAR T cell Immunotherapy to the Next Level
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
More than a decade ago, doctors at the University of Pennsylvania treated a patient with her own T cells, which had been engineered to recognize and target the cancer cells in her body. The treatment, which is called CAR T cell immunotherapy, is now widely used for patients with leukemia, lymphoma, and myeloma. Today, scientists like Saul Priceman are working to take this therapy to the next level, making it effective against as many cancer types as possible. He talked with Chuck and Alicia about what his lab is doing to improve CAR T cell immunotherapy.
adbl_web_anon_alc_button_suppression_t1
No reviews yet